as soon as is submitted to ZB.
Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas.
J. Clin. Oncol. 20, 3156-3164 (2002)
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS).Patients and Methods: From 1991 to 1997, 58 patients with HR-STS at RP/V sites were prospectively treated with four cycles of etoposide, ifosfamide, and doxorubicin combined with RHT followed by surgery, adjuvant chemotherapy, and radiation.
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
PROGNOSTIC FACTORS; PHASE-II; PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EXTREMITY; HEAT; TRIAL; MANAGEMENT; RADIATION
ISSN (print) / ISBN
0732-183X
e-ISSN
1527-7755
Quellenangaben
Volume: 20,
Pages: 3156-3164
Publisher
American Society of Clinical Oncology
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
CCG Tumor Therapy with Hyperthermia (IMI-KTH)